Pivotal
Pivotal was founded in 2012 and is headquartered in San Francisco, US
Report incorrect company information
Key People/Management at Pivotal
Paul Maritz
Chairman of the Board
Rob Mee
CEO
Bill Cook
President
Scott Yara
Senior Vice President, Products
Andy Cohen
General Counsel
Cynthia Gaylor
CFO
Report incorrect company information
Pivotal Office Locations
Pivotal has offices in San Francisco, Singapore, London, Cambridge and in 10 other locations
San Francisco, US (HQ)
875 Howard St
Arlington, US
2221 S Clark St
Boulder, US
200 1701 Pearl St
Cambridge, US
145 Broadway
Chicago, US
1214 222 W Merchandise Mart Plaza
Denver, US
1644 Platte St
Report incorrect company information
Pivotal Financials and Metrics
Pivotal Financials
Pivotal's revenue was reported to be $509.44 m in FY, 2018 which is a 22.4% increase from the previous period.
| USD | |
|---|---|
Revenue (FY, 2018) | 509.4 m |
Revenue growth (FY, 2017 - FY, 2018), % | 22.4% |
Gross profit (FY, 2018) | 281 m |
Gross profit margin (FY, 2018), % | 55.2% |
Net income (FY, 2018) | (163.5 m) |
EBIT (FY, 2018) | (168.3 m) |
Cash (2-Feb-2018) | 73 m |
Annual
| USD | FY, 2017 | FY, 2018 |
|---|---|---|
Cash | 133.9 m | 73 m |
Accounts Receivable | 145.4 m | 210.7 m |
Current Assets | 328.7 m | 366.7 m |
PP&E | 29 m | 32 m |
| USD | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
Net Income | (282.7 m) | (232.9 m) | (163.5 m) |
Depreciation and Amortization | 32.8 m | 24.6 m | 22.2 m |
Accounts Payable | (300 k) | (6 m) | 12.6 m |
Cash From Operating Activities | 29.2 m | (166.4 m) | (116.5 m) |
| USD | Y, 2018 |
|---|---|
Revenue/Employee | 268 k |
Financial Leverage | 1.6 x |
Pivotal Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Neo Innovation, Inc. | February 28, 2016 | |
| Slice of Lime | January 12, 2016 | |
| CloudCredo | December 21, 2015 | |
| Xtreme Labs Inc | October 02, 2013 | |
| Cubox | ||
| New Context (Singapore) | ||
| Proof Innovation Labs |
Pivotal Revenue Breakdown
Pivotal revenue breakdown by business segment: 66.2% from Services and 33.8% from Subscription
Report incorrect company information
Pivotal Online and Social Media Presence
Report incorrect company information
Pivotal News and Updates
June 22, 2018
Mezzion Pharma and NHLBI-Funded Pediatric Heart Network Complete Enrollment in a Pivotal Phase 3 Clinical Trial of Udenafil in Adolescents with Fontan Surgical Palliation - an Orphan Drug Indication
SEOUL, South Korea and BETHESDA, Md., June 22, 2018 /PRNewswire/ -- Mezzion Pharma and the National Heart, Lung, and Blood Institute (NHLBI) today announced that it has completed enrollment of their FUEL trial, a pivotal Phase 3 efficacy and safety trial of udenafil for the treatment of...
June 22, 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
SEATTLE, June 22, 2018 /PRNewswire/ -- Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that...
June 22, 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
SEATTLE, June 22, 2018 /PRNewswire/ -- Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that...
June 22, 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
SEATTLE, June 22, 2018 /PRNewswire/ -- Impel NeuroPharma, a Seattle-based, privately-held biotechnology company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that...
June 19, 2018
Maxor Appoints New CFO at Pivotal Point in the Company's Transformation
AMARILLO, Texas, June 19, 2018 /PRNewswire/ -- Maxor National Pharmacy Services, LLC (Maxor) today announced the appointment of David G. Wheeler, CPA as Chief Financial Officer. Wheeler brings decades of executive leadership experience to Maxor, including more than fifteen years of experi...
June 18, 2018
Pivotal: A Long Time Coming
Report incorrect company information